C. Angers and . Laboratoire-d-'h-ematologie,

C. and I. ,

, Ouest Against Leukemia' (FHU GOAL)

C. De and B. ,

C. De-nantes and . Laboratoire-d-'h-ematologie, , p.12

. Ufr-m-edecine, 13 CHU d'Angers, Service des Maladies du Sang

A. and C. H. Mondor, , p.15

P. Bordeaux and N. Aquitaine, Service d'h emato-oncologie, 16 INSERM 1066 MINT, p.17

R. Service-de-m-edecine-h-ematologie and . Boulin, 18 CHU de Limoges

, Service de M edecine Interne-Maladies Infectieuses

C. Eric-lippert, . Md, . Phd, and C. Laboratoire-d-'h-ematologie,

O. Mansier and D. , Luque Paz contributed equally to this work Funding information French National Institute of Cancer, Award/grant number

, Ministère de l'Enseignement Sup erieur et de la Recherche REFERENCES

S. Langabeer, H. Andrikovics, and J. Asp, Molecular diagnostics of myeloproliferative neoplasms, European Journal of Haematology, vol.37, issue.S1, pp.270-279, 2015.
DOI : 10.1111/ijlh.12269

URL : https://hal.archives-ouvertes.fr/hal-01916333

N. Xu, L. Ding, and C. Yin, A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients, Annals of Hematology, vol.14, issue.10, pp.865-867, 2015.
DOI : 10.1179/102453309X12473408860587

F. Usseglio, N. Beaufils, A. Calleja, S. Raynaud, and J. Gabert, Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia, The Journal of Molecular Diagnostics, vol.19, issue.1, pp.92-98, 2017.
DOI : 10.1016/j.jmoldx.2016.08.006

URL : https://hal.archives-ouvertes.fr/hal-01766867

G. Mcgaffin, K. Harper, D. Stirling, and L. Mclintock, mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort, British Journal of Haematology, vol.369, issue.2, pp.276-278, 2014.
DOI : 10.1038/leu.2014.3

O. Mansier, M. Migeon, G. Etienne, A. Bidet, and E. Lippert, V617F allelic burdens, Leukemia & Lymphoma, vol.57, issue.8, pp.1949-1951, 2016.
DOI : 10.1182/blood-2013-11-537167

C. Nielsen, S. Bojesen, B. Nordestgaard, K. Kofoed, and H. Birgens, JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate, Haematologica, vol.99, issue.9, pp.1448-1455, 2014.
DOI : 10.3324/haematol.2014.107631